New Alzheimer’s Drug Repairs DNA and Reduces Brain Inflammation: What the July 2026 Breakthrough Means
A July 17, 2026 study found KCL-286, originally developed for spinal cord injury, repaired DNA damage and reduced Alzheimer’s neuroinflammation simultaneously in mice. A 40-year pharmacist explains why this multi-pathway approach matters, where it stands in the treatment pipeline, and what Americans can do now for Alzheimer’s prevention.